SCHEMBL17486276

SCHEMBL17486276

CN1C(C)(C)c2ccc(-c3ccc(Br)cn3)cc2C1(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.36
NFKB1 P19838 2/20 0.36
RAB9A P51151 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 1/20 0.33
CA2 P00918 1/20 0.32
PGR P06401 1/20 0.32
BACE1 P56817 2/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
APP P05067 1/20 0.31
RXFP1 Q9HBX9 1/20 0.30
TP53 P04637 1/20 0.30
GAA P10253 1/20 0.30
IDO1 P14902 1/20 0.30
TDO2 P48775 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15615001 0.79 TDO2 (0.33) NPC1RAB9AALDH1A1BACE1TDO2
SCHEMBL17486007 0.79 JAK2 (0.31)
SCHEMBL17477823 0.78 NPC1 (0.38) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL18015415 0.77 NPC1 (0.37) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL18015246 0.77 RARA (0.44) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL20007152 0.77 NPC1 (0.37) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL17486216 0.77 MAPK1 (0.37) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL17486072 0.76 BACE1 (0.33) NPC1RAB9ASMN1; SMN2BACE1HSD17B1
SCHEMBL15614854 0.76 AKR1B1 (0.35) SMN1; SMN2PGRBACE1TP53
SCHEMBL17486120 0.76 NPC1 (0.36) NPC1NFKB1RAB9ANFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 NPC1 3516/4885NFKB1 1929/4885RAB9A 2201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.